Trial NCT04272775

View at ClinicalTrials.gov 
Org. Study IDs: TB-MC010034
Secondary IDs: JapicCTI-121822 U1111-1243-1737

Last trial update was posted on 2020-03-17

MeSH Interventions

Dexamethasone Ixazomib Lenalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Relapsed and/or Refractory Multiple Myeloma

Stopping Reasons

Business Decision; No Safety Or Efficacy Concerns

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID